Durect Corp (DRRX)

DURECT Corporation Stock (DRRX) dropped by 79.57% from $2.58 to $0.527 in the trading on Wednesday November 8, 2023. The reason why DRRX stock down today is due to failed alcohol-associated hepatitis trial. Durect's topline results from Phase 2B AHFIRM trial of larsucosterol in alcohol-associated hepatitis did not achieve statistical significance for either dose on the primary endpoint of mortality or transplant at 90 days.